Glenmark Pharmaceuticals Limited
₹1,533.7
INR-5.70(-0.37%)
As of November 14, 2024 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹47125.40 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹46833.22 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
86.24
Forward P/E
Price to Earnings ratio based on forecasted earnings
39.31
PEG Ratio
Price/Earnings to Growth ratio
39.31
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
3.66
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
65.56%
Operating Margin
Operating income as a percentage of revenue
14.50%
Return on Equity
Net income as a percentage of shareholders' equity
-19.14%
Revenue (TTM)
Total revenue over trailing 12 months
₹12861.21 Cr-4.6%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹2084.23 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹-55.78+126.89999999999999%
Balance Sheet
Total Cash
Total cash and short-term investments
₹1659.46 Cr
Total Debt
Total short-term and long-term debt
₹1230.93 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
15.69%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹722.1 - ₹1830.95
Beta
Measure of stock's volatility compared to the market
0.87
Shares Outstanding
Total number of shares issued by the company
₹28.22 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.59%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.00%
Payout Ratio
Percentage of earnings paid as dividends
27.72%